Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failed trials
Pharma
Argenx calls it quits on Vyvgart Hytrulo Sjögren's disease trial
Shortly after teeing up Vyvgart Hytrulo for entry into another potential immunology niche, argenx has stumbled against a separate target.
Fraiser Kansteiner
Oct 8, 2026 10:44am
AstraZeneca’s Etcamah flunks first-line breast cancer trial
Sep 12, 2026 12:43pm
Karyopharm reports Xpovio miss, FDA filing in separate cancers
Jul 31, 2026 10:00am
Fierce Biotech
Sanofi CEO ‘looking deeply’ at pipeline as clearout continues
Jul 30, 2026 3:27am
BMS details Krazati confirmatory fail in colorectal cancer
Jul 7, 2026 10:46am
Insmed terminates development of Brinsupri in another indication
Apr 8, 2026 7:57am
